Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational investigation of single herbal drugs for diabetes and obesity using knowledge graph and network pharmacology.

Computational biology and chemistry·2026
Same author

Node persistence from topological data analysis reveals changes in brain functional connectivity.

Patterns (New York, N.Y.)·2026
Same author

Sec and Tat Mediated Secretion Safeguards Mycobacterium tuberculosis Membrane Homeostasis.

Molecular & cellular proteomics : MCP·2026
Same author

Integrative network-based construction of ecologically relevant computational adverse outcome pathways for organic mercury-induced toxicity.

Environmental toxicology and chemistry·2026
Same author

Network toxicology focused investigation on the impacts of inorganic arsenic and cadmium on human and ecosystem health.

Environmental toxicology and chemistry·2025
Same author

The dawn of a new air pollutant: inhalable microplastics as emerging vectors of hazardous contaminants and their implications for human health.

Environment international·2025

Related Experiment Video

Updated: Jun 13, 2026

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
11:07

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

Challenges in experimental data integration within genome-scale metabolic models.

Pierre-Yves Bourguignon1, Areejit Samal, François Képès

  • 1Max Planck Institute for Mathematics in the Sciences, Inselstr, 22, D-04103 Leipzig, Germany.

Algorithms for Molecular Biology : AMB
|April 24, 2010
PubMed
Summary

This report summarizes a meeting on integrating experimental data into genome-scale metabolic models. Key challenges and future directions in systems biology were discussed.

More Related Videos

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data
07:11

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data

Published on: November 10, 2023

Related Experiment Videos

Last Updated: Jun 13, 2026

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
11:07

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data
07:11

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data

Published on: November 10, 2023

Area of Science:

  • Systems Biology
  • Metabolic Modeling
  • Bioinformatics

Background:

  • Genome-scale metabolic models (GSMMs) are crucial for understanding cellular metabolism.
  • Integrating diverse experimental data into GSMMs presents significant challenges.
  • Advancements in systems biology require robust data integration strategies.

Purpose of the Study:

  • To report on the "Challenges in experimental data integration within genome-scale metabolic models" meeting.
  • To identify key obstacles and potential solutions for data integration in metabolic modeling.
  • To foster collaboration and discussion among researchers in systems biology.

Main Methods:

  • The content is based on discussions and presentations from a dedicated workshop.
  • Expert insights were gathered on current methodologies and limitations.
  • A collaborative approach to problem-solving was employed.

Main Results:

  • Several critical challenges in experimental data integration were highlighted.
  • Gaps in current methodologies and data standardization were identified.
  • Future research directions and collaborative efforts were proposed.

Conclusions:

  • Effective integration of experimental data is essential for advancing genome-scale metabolic models.
  • Addressing data heterogeneity and quality is paramount for accurate modeling.
  • Continued interdisciplinary collaboration is vital for progress in systems biology.